| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |